HEADER OXIDOREDUCTASE 22-JAN-08 3C1A TITLE CRYSTAL STRUCTURE OF A PUTATIVE OXIDOREDUCTASE (ZP_00056571.1) FROM TITLE 2 MAGNETOSPIRILLUM MAGNETOTACTICUM MS-1 AT 1.85 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE OXIDOREDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MAGNETOSPIRILLUM MAGNETOTACTICUM; SOURCE 3 ORGANISM_TAXID: 272627; SOURCE 4 STRAIN: MS-1; SOURCE 5 GENE: ZP_00056571.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS ZP_00056571.1, A PUTATIVE OXIDOREDUCTASE, OXIDOREDUCTASE FAMILY, NAD- KEYWDS 2 BINDING ROSSMANN FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 3 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 4 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 30-OCT-24 3C1A 1 REMARK REVDAT 5 01-FEB-23 3C1A 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3C1A 1 REMARK REVDAT 3 13-JUL-11 3C1A 1 VERSN REVDAT 2 24-FEB-09 3C1A 1 VERSN REVDAT 1 05-FEB-08 3C1A 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE OXIDOREDUCTASE JRNL TITL 2 (ZP_00056571.1) FROM MAGNETOSPIRILLUM MAGNETOTACTICUM MS-1 JRNL TITL 3 AT 1.85 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 61925 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3136 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4225 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 240 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4476 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 644 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.02000 REMARK 3 B22 (A**2) : 2.30000 REMARK 3 B33 (A**2) : -1.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.151 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.809 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4733 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3108 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6491 ; 1.503 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7633 ; 0.960 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 640 ; 6.017 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 163 ;36.984 ;23.742 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 697 ;12.619 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;19.426 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 755 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5383 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 875 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 959 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3288 ; 0.198 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2254 ; 0.170 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2425 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 509 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 3 ; 0.081 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.246 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 72 ; 0.266 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 38 ; 0.180 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3228 ; 2.060 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1268 ; 0.626 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5066 ; 2.895 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1715 ; 4.870 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1425 ; 6.828 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 8 A 314 4 REMARK 3 1 B 8 B 314 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 3673 ; 0.210 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 3673 ; 0.820 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN RIDING POSITIONS. REMARK 3 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. REMARK 3 4. PEG 3350 FRAGMENTS (PEG, PGE AND PG4) FROM CRYSTALLIZATION REMARK 3 SOLUTION ARE MODELED. REMARK 3 5. RAMACHANDRAN OUTLIER OF RESIDUE PRO 259 IN THE B-SUBUNIT REMARK 3 IS LOCATED IN POOR DENSITY. REMARK 3 6. ELECTRON DENSITY ALONG THE CRYSTALLOGRAPHIC TWO-FOLD AXIS NEAR REMARK 3 THE SIDECHAIN OF THR B249 IS DISORDERED AND PRECLUDED THE RELIABLE REMARK 3 MODELING OF THIS SIDECHAIN. REMARK 4 REMARK 4 3C1A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046215. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840, 0.97953, 0.97939 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : ADJUSTABLE FOCUSING MIRRORS IN K REMARK 200 -B GEOMETRY REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61976 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 29.988 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : 0.14500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.88500 REMARK 200 R SYM FOR SHELL (I) : 0.88500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 19.6% PEG 3350, 0.15M DI REMARK 280 -AMMONIUM TARTRATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 47.32900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.18050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.32900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.18050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A REMARK 300 MONOMER AS A SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 553 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 ILE A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 ASN A 6 REMARK 465 ASN A 7 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 ILE B 3 REMARK 465 PRO B 4 REMARK 465 ALA B 5 REMARK 465 ASN B 6 REMARK 465 ASN B 7 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 26 CZ NH1 NH2 REMARK 470 LYS A 99 CE NZ REMARK 470 GLU A 199 CD OE1 OE2 REMARK 470 LYS A 229 CD CE NZ REMARK 470 ARG A 231 CD NE CZ NH1 NH2 REMARK 470 ARG A 247 CG CD NE CZ NH1 NH2 REMARK 470 THR A 249 OG1 CG2 REMARK 470 LYS A 251 NZ REMARK 470 GLN A 267 CG CD OE1 NE2 REMARK 470 ARG B 26 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 47 CG CD1 CD2 REMARK 470 LYS B 229 CD CE NZ REMARK 470 ARG B 231 CZ NH1 NH2 REMARK 470 ARG B 247 CG CD NE CZ NH1 NH2 REMARK 470 THR B 249 OG1 CG2 REMARK 470 LYS B 251 NZ REMARK 470 ASP B 275 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 305 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 22 -156.48 22.25 REMARK 500 ASN A 23 39.10 -84.46 REMARK 500 ALA A 75 58.86 -118.80 REMARK 500 SER A 215 -109.19 48.76 REMARK 500 LYS B 22 -139.80 -18.44 REMARK 500 ASN B 23 35.63 -91.25 REMARK 500 SER B 215 -107.68 51.38 REMARK 500 ASP B 275 68.91 -106.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 316 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 375584 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. REMARK 999 2. THE SEQUENCE OF THIS PROTEIN WAS NOT AVAILABLE AT THE REMARK 999 UNIPROT KNOWLEDGEBASE DATABASE (UNIPROTKB) AT THE TIME OF REMARK 999 DEPOSITION. THE SEQUENCE INFORMATION IS AVAILABLE AT GENBANK REMARK 999 WITH ACCESSION CODE ZP_00056571.1 AND IN THE UNIPROT ARCHIVE REMARK 999 (UNIPARC) WITH ACCESSION CODE UPI0000384B0A. DBREF 3C1A A 0 314 PDB 3C1A 3C1A 0 314 DBREF 3C1A B 0 314 PDB 3C1A 3C1A 0 314 SEQADV 3C1A GLY A 0 PDB 3C1A EXPRESSION TAG SEQADV 3C1A GLY B 0 PDB 3C1A EXPRESSION TAG SEQRES 1 A 315 GLY MSE SER ILE PRO ALA ASN ASN SER PRO VAL ARG LEU SEQRES 2 A 315 ALA LEU ILE GLY ALA GLY ARG TRP GLY LYS ASN TYR ILE SEQRES 3 A 315 ARG THR ILE ALA GLY LEU PRO GLY ALA ALA LEU VAL ARG SEQRES 4 A 315 LEU ALA SER SER ASN PRO ASP ASN LEU ALA LEU VAL PRO SEQRES 5 A 315 PRO GLY CYS VAL ILE GLU SER ASP TRP ARG SER VAL VAL SEQRES 6 A 315 SER ALA PRO GLU VAL GLU ALA VAL ILE ILE ALA THR PRO SEQRES 7 A 315 PRO ALA THR HIS ALA GLU ILE THR LEU ALA ALA ILE ALA SEQRES 8 A 315 SER GLY LYS ALA VAL LEU VAL GLU LYS PRO LEU THR LEU SEQRES 9 A 315 ASP LEU ALA GLU ALA GLU ALA VAL ALA ALA ALA ALA LYS SEQRES 10 A 315 ALA THR GLY VAL MSE VAL TRP VAL GLU HIS THR GLN LEU SEQRES 11 A 315 PHE ASN PRO ALA TRP GLU ALA LEU LYS ALA ASP LEU THR SEQRES 12 A 315 SER ILE GLY PRO ILE LEU ALA VAL ARG SER GLU ALA GLY SEQRES 13 A 315 ASN HIS GLY PRO TYR ARG PRO GLY GLY VAL PRO MSE LEU SEQRES 14 A 315 TRP ASP TRP GLY ALA HIS ASP VAL SER MSE VAL LEU ASP SEQRES 15 A 315 LEU MSE GLY ARG ASP PRO ASP SER THR SER ALA SER TRP SEQRES 16 A 315 ALA ALA ARG GLY GLU LYS ASP GLY GLY GLU ALA GLY ASP SEQRES 17 A 315 VAL THR LEU THR LEU ALA PHE SER THR VAL GLU ALA HIS SEQRES 18 A 315 ILE ARG LEU CYS ASN THR MSE ASP LYS CYS ARG ARG LEU SEQRES 19 A 315 ALA VAL PHE GLY GLU ALA GLY THR LEU VAL MSE ASP ASP SEQRES 20 A 315 ARG ALA THR ASP LYS LEU THR LEU HIS PRO PRO GLN PRO SEQRES 21 A 315 ASP GLY ASN TRP PRO VAL GLY GLN GLY HIS ALA LEU THR SEQRES 22 A 315 VAL THR ASP GLU MSE PRO LEU THR ARG ALA VAL ARG LEU SEQRES 23 A 315 PHE ALA GLY ALA VAL ARG GLN PRO GLU PRO GLY PRO SER SEQRES 24 A 315 PRO LEU GLU LEU GLY LEU ARG VAL VAL ARG VAL LEU GLY SEQRES 25 A 315 ALA CYS SER SEQRES 1 B 315 GLY MSE SER ILE PRO ALA ASN ASN SER PRO VAL ARG LEU SEQRES 2 B 315 ALA LEU ILE GLY ALA GLY ARG TRP GLY LYS ASN TYR ILE SEQRES 3 B 315 ARG THR ILE ALA GLY LEU PRO GLY ALA ALA LEU VAL ARG SEQRES 4 B 315 LEU ALA SER SER ASN PRO ASP ASN LEU ALA LEU VAL PRO SEQRES 5 B 315 PRO GLY CYS VAL ILE GLU SER ASP TRP ARG SER VAL VAL SEQRES 6 B 315 SER ALA PRO GLU VAL GLU ALA VAL ILE ILE ALA THR PRO SEQRES 7 B 315 PRO ALA THR HIS ALA GLU ILE THR LEU ALA ALA ILE ALA SEQRES 8 B 315 SER GLY LYS ALA VAL LEU VAL GLU LYS PRO LEU THR LEU SEQRES 9 B 315 ASP LEU ALA GLU ALA GLU ALA VAL ALA ALA ALA ALA LYS SEQRES 10 B 315 ALA THR GLY VAL MSE VAL TRP VAL GLU HIS THR GLN LEU SEQRES 11 B 315 PHE ASN PRO ALA TRP GLU ALA LEU LYS ALA ASP LEU THR SEQRES 12 B 315 SER ILE GLY PRO ILE LEU ALA VAL ARG SER GLU ALA GLY SEQRES 13 B 315 ASN HIS GLY PRO TYR ARG PRO GLY GLY VAL PRO MSE LEU SEQRES 14 B 315 TRP ASP TRP GLY ALA HIS ASP VAL SER MSE VAL LEU ASP SEQRES 15 B 315 LEU MSE GLY ARG ASP PRO ASP SER THR SER ALA SER TRP SEQRES 16 B 315 ALA ALA ARG GLY GLU LYS ASP GLY GLY GLU ALA GLY ASP SEQRES 17 B 315 VAL THR LEU THR LEU ALA PHE SER THR VAL GLU ALA HIS SEQRES 18 B 315 ILE ARG LEU CYS ASN THR MSE ASP LYS CYS ARG ARG LEU SEQRES 19 B 315 ALA VAL PHE GLY GLU ALA GLY THR LEU VAL MSE ASP ASP SEQRES 20 B 315 ARG ALA THR ASP LYS LEU THR LEU HIS PRO PRO GLN PRO SEQRES 21 B 315 ASP GLY ASN TRP PRO VAL GLY GLN GLY HIS ALA LEU THR SEQRES 22 B 315 VAL THR ASP GLU MSE PRO LEU THR ARG ALA VAL ARG LEU SEQRES 23 B 315 PHE ALA GLY ALA VAL ARG GLN PRO GLU PRO GLY PRO SER SEQRES 24 B 315 PRO LEU GLU LEU GLY LEU ARG VAL VAL ARG VAL LEU GLY SEQRES 25 B 315 ALA CYS SER MODRES 3C1A MSE A 121 MET SELENOMETHIONINE MODRES 3C1A MSE A 167 MET SELENOMETHIONINE MODRES 3C1A MSE A 178 MET SELENOMETHIONINE MODRES 3C1A MSE A 183 MET SELENOMETHIONINE MODRES 3C1A MSE A 227 MET SELENOMETHIONINE MODRES 3C1A MSE A 244 MET SELENOMETHIONINE MODRES 3C1A MSE A 277 MET SELENOMETHIONINE MODRES 3C1A MSE B 121 MET SELENOMETHIONINE MODRES 3C1A MSE B 167 MET SELENOMETHIONINE MODRES 3C1A MSE B 178 MET SELENOMETHIONINE MODRES 3C1A MSE B 183 MET SELENOMETHIONINE MODRES 3C1A MSE B 227 MET SELENOMETHIONINE MODRES 3C1A MSE B 244 MET SELENOMETHIONINE MODRES 3C1A MSE B 277 MET SELENOMETHIONINE HET MSE A 121 8 HET MSE A 167 8 HET MSE A 178 16 HET MSE A 183 8 HET MSE A 227 8 HET MSE A 244 8 HET MSE A 277 8 HET MSE B 121 8 HET MSE B 167 8 HET MSE B 178 8 HET MSE B 183 8 HET MSE B 227 8 HET MSE B 244 8 HET MSE B 277 16 HET PG4 A 315 13 HET PEG A 316 7 HET PGE B 315 10 HETNAM MSE SELENOMETHIONINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PGE TRIETHYLENE GLYCOL FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 PG4 C8 H18 O5 FORMUL 4 PEG C4 H10 O3 FORMUL 5 PGE C6 H14 O4 FORMUL 6 HOH *644(H2 O) HELIX 1 1 ASN A 23 LEU A 31 1 9 HELIX 2 2 ASN A 43 ALA A 48 1 6 HELIX 3 3 TRP A 60 SER A 65 1 6 HELIX 4 4 PRO A 77 ALA A 79 5 3 HELIX 5 5 THR A 80 SER A 91 1 12 HELIX 6 6 ASP A 104 GLY A 119 1 16 HELIX 7 7 HIS A 126 PHE A 130 5 5 HELIX 8 8 ASN A 131 ASP A 140 1 10 HELIX 9 9 ASP A 140 GLY A 145 1 6 HELIX 10 10 PRO A 166 GLY A 184 1 19 HELIX 11 11 MSE A 277 VAL A 290 1 14 HELIX 12 12 PRO A 299 SER A 314 1 16 HELIX 13 13 ASN B 23 GLY B 30 1 8 HELIX 14 14 ASN B 43 ALA B 48 1 6 HELIX 15 15 ASP B 59 SER B 65 1 7 HELIX 16 16 PRO B 77 ALA B 79 5 3 HELIX 17 17 THR B 80 GLY B 92 1 13 HELIX 18 18 ASP B 104 GLY B 119 1 16 HELIX 19 19 HIS B 126 PHE B 130 5 5 HELIX 20 20 ASN B 131 ASP B 140 1 10 HELIX 21 21 LEU B 141 GLY B 145 5 5 HELIX 22 22 PRO B 166 GLY B 184 1 19 HELIX 23 23 MSE B 277 VAL B 290 1 14 HELIX 24 24 PRO B 299 CYS B 313 1 15 SHEET 1 A 6 VAL A 55 GLU A 57 0 SHEET 2 A 6 ALA A 34 SER A 41 1 N LEU A 39 O GLU A 57 SHEET 3 A 6 VAL A 10 GLY A 16 1 N LEU A 12 O ALA A 35 SHEET 4 A 6 ALA A 71 ALA A 75 1 O ILE A 73 N ILE A 15 SHEET 5 A 6 ALA A 94 GLU A 98 1 O ALA A 94 N VAL A 72 SHEET 6 A 6 VAL A 122 GLU A 125 1 O GLU A 125 N VAL A 97 SHEET 1 B 8 SER A 189 LYS A 200 0 SHEET 2 B 8 GLY A 203 PHE A 214 -1 O GLY A 203 N LYS A 200 SHEET 3 B 8 VAL A 217 CYS A 224 -1 O VAL A 217 N PHE A 214 SHEET 4 B 8 ILE A 147 HIS A 157 1 N SER A 152 O ARG A 222 SHEET 5 B 8 THR A 226 GLY A 237 -1 O CYS A 230 N GLY A 155 SHEET 6 B 8 THR A 241 ASP A 245 -1 O LEU A 242 N VAL A 235 SHEET 7 B 8 THR A 253 HIS A 255 -1 O HIS A 255 N THR A 241 SHEET 8 B 8 HIS A 269 ALA A 270 -1 O HIS A 269 N LEU A 254 SHEET 1 C 6 VAL B 55 GLU B 57 0 SHEET 2 C 6 ALA B 34 SER B 41 1 N LEU B 39 O GLU B 57 SHEET 3 C 6 VAL B 10 GLY B 16 1 N LEU B 12 O ALA B 35 SHEET 4 C 6 ALA B 71 ALA B 75 1 O ALA B 75 N ILE B 15 SHEET 5 C 6 ALA B 94 GLU B 98 1 O LEU B 96 N ILE B 74 SHEET 6 C 6 VAL B 122 GLU B 125 1 O TRP B 123 N VAL B 95 SHEET 1 D 8 SER B 189 LYS B 200 0 SHEET 2 D 8 GLY B 203 PHE B 214 -1 O THR B 211 N SER B 191 SHEET 3 D 8 VAL B 217 CYS B 224 -1 O ILE B 221 N LEU B 210 SHEET 4 D 8 ILE B 147 HIS B 157 1 N SER B 152 O ARG B 222 SHEET 5 D 8 THR B 226 GLY B 237 -1 O PHE B 236 N LEU B 148 SHEET 6 D 8 THR B 241 ASP B 245 -1 O MSE B 244 N LEU B 233 SHEET 7 D 8 THR B 253 HIS B 255 -1 O THR B 253 N VAL B 243 SHEET 8 D 8 HIS B 269 ALA B 270 -1 O HIS B 269 N LEU B 254 LINK C VAL A 120 N MSE A 121 1555 1555 1.33 LINK C MSE A 121 N VAL A 122 1555 1555 1.35 LINK C PRO A 166 N MSE A 167 1555 1555 1.34 LINK C MSE A 167 N LEU A 168 1555 1555 1.33 LINK C SER A 177 N AMSE A 178 1555 1555 1.33 LINK C SER A 177 N BMSE A 178 1555 1555 1.34 LINK C AMSE A 178 N VAL A 179 1555 1555 1.33 LINK C BMSE A 178 N VAL A 179 1555 1555 1.33 LINK C LEU A 182 N MSE A 183 1555 1555 1.33 LINK C MSE A 183 N GLY A 184 1555 1555 1.33 LINK C THR A 226 N MSE A 227 1555 1555 1.33 LINK C MSE A 227 N ASP A 228 1555 1555 1.33 LINK C VAL A 243 N MSE A 244 1555 1555 1.33 LINK C MSE A 244 N ASP A 245 1555 1555 1.33 LINK C GLU A 276 N MSE A 277 1555 1555 1.33 LINK C MSE A 277 N PRO A 278 1555 1555 1.34 LINK C VAL B 120 N MSE B 121 1555 1555 1.32 LINK C MSE B 121 N VAL B 122 1555 1555 1.35 LINK C PRO B 166 N MSE B 167 1555 1555 1.34 LINK C MSE B 167 N LEU B 168 1555 1555 1.34 LINK C SER B 177 N MSE B 178 1555 1555 1.34 LINK C MSE B 178 N VAL B 179 1555 1555 1.33 LINK C LEU B 182 N MSE B 183 1555 1555 1.33 LINK C MSE B 183 N GLY B 184 1555 1555 1.32 LINK C THR B 226 N MSE B 227 1555 1555 1.32 LINK C MSE B 227 N ASP B 228 1555 1555 1.33 LINK C VAL B 243 N MSE B 244 1555 1555 1.33 LINK C MSE B 244 N ASP B 245 1555 1555 1.32 LINK C GLU B 276 N AMSE B 277 1555 1555 1.33 LINK C GLU B 276 N BMSE B 277 1555 1555 1.33 LINK C AMSE B 277 N PRO B 278 1555 1555 1.35 LINK C BMSE B 277 N PRO B 278 1555 1555 1.35 CISPEP 1 LYS A 99 PRO A 100 0 -9.10 CISPEP 2 GLY A 158 PRO A 159 0 7.13 CISPEP 3 LYS B 99 PRO B 100 0 -11.43 CISPEP 4 GLY B 158 PRO B 159 0 3.69 SITE 1 AC1 11 GLN A 128 ASN A 131 SER A 152 GLU A 153 SITE 2 AC1 11 HIS A 174 ASP A 175 ARG A 231 ARG A 232 SITE 3 AC1 11 ASP A 246 HOH A 367 HOH A 494 SITE 1 AC2 10 GLN B 128 ASN B 131 GLU B 153 HIS B 174 SITE 2 AC2 10 ASP B 175 ARG B 231 ARG B 232 MSE B 244 SITE 3 AC2 10 HOH B 552 HOH B 558 SITE 1 AC3 5 GLY A 155 ASN A 156 LYS A 229 CYS A 230 SITE 2 AC3 5 ARG A 231 CRYST1 94.658 86.361 87.907 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010564 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011376 0.00000